Millipore Sigma Vibrant Logo

MABF288 Anti-Roquin-1/2, clone 3F12 Antibody

View This Product on Sigma-Aldrich
MABF288
100 µg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited Availability
Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      H, MWB, IPRPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMABF288
      DescriptionAnti-Roquin-1/2, clone 3F12 Antibody
      Alternate Names
      • Roquin-1
      • Roquin
      • RING finger and C3H zinc finger protein 1
      • RING finger and CCCH-type zinc finger domain-containing protein 1
      • RING finger protein 198
      Background InformationRoquin-1 shares 46% identity with Roquin-2 and both serve the same function and belong to the Zinc finger family of RNA binding proteins. Roquin-1/2 are cytoplasmic RNA suppression proteins that specifically bind selective RNAs and promote the deadenylation of mature mRNAs and their degradation. Roquin-1/2s targets include HMGXB3, ICOS, IER3, NFKBID, NFKBIZ, PPP1R10, TNF and in many more critical RNAs. In particular, because of their impact on ICSO and gamma interferon and T helper cell activation, Roquin-1/2 are being examined as mediators of the systemic inflammation response and controllers of adaptive and innate immune responses in autoimmune disease. Roquin 1/2 are widely expressed and localized in the cytoplasm and/or P bodies and cytosolic stress granules when under cellular stress.
      References
      Product Information
      FormatPurified
      PresentationPurified rat monoclonal IgG2aκ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationThis Anti-Roquin-1/2, clone 3F12 Antibody is validated for use in Western Blotting and Immunoprecipitation for the detection of Roquin-1/2.
      Key Applications
      • Western Blotting
      • Immunoprecipitation
      Application NotesWestern Blotting Analysis: A representative lot detected Roquin-1/2 in both Roquin-1 & Roquin-2 in normal MEFs, only Roquin-2 and Roquin-1 deficient MEFs, and neither protein in Roquin-1/2 deficient MEFs. This antibody also detected Roquin-1 and Roquin-2 in Mouse Spleen, Lymph Node, Thymus, Brain & Lung tissue, CD4+ T cells and Thymocyte lysates (Vogel, K.U., et al. (2013). Immunity. 38:655-668).
      Immunoprecipitation Analysis: A representative lot immunoprecipitated Roquin-1/2 in MEF cell lysate (Vogel, K.U., et al. (2013). Immunity. 38:655-668).
      Biological Information
      ImmunogenRecombinant protein corresponding to human Roquin-1/2.
      Clone3F12
      ConcentrationPlease refer to lot specific datasheet.
      HostRat
      SpecificityThis antibody specifically detects both Roquin-1 & Roquin-2 (Vogel, K.U., et al. (2013). Immunity. 38:655-668).
      IsotypeIgG2aκ
      Species Reactivity
      • Human
      • Mouse
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • RC3H1
      • KIAA2025
      • RNF198
      Purification MethodProtein G Purified
      UniProt Number
      Molecular Weight125 kDa calculated
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      MABF288 04055977112702

      Documentation

      Anti-Roquin-1/2, clone 3F12 Antibody SDS

      Title

      Safety Data Sheet (SDS) 

      Anti-Roquin-1/2, clone 3F12 Antibody Certificates of Analysis

      TitleLot Number
      Anti-Roquin-1/2, clone 3F12 3072847
      Anti-Roquin-1/2, clone 3F12 Q2476915
      Anti-Roquin-1/2, clone 3F12 - 3275538 3275538
      Anti-Roquin-1/2, clone 3F12 - 3548395 3548395
      Anti-Roquin-1/2, clone 3F12 - 3610037 3610037
      Anti-Roquin-1/2, clone 3F12 - 3778059 3778059
      Anti-Roquin-1/2, clone 3F12 - 3819946 3819946
      Anti-Roquin-1/2, clone 3F12 - 3834616 3834616
      Anti-Roquin-1/2, clone 3F12 - 3940719 3940719
      Anti-Roquin-1/2, clone 3F12 - 4204604 4204604

      References

      Reference overviewPub Med ID
      Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote TH17 differentiation.
      Jeltsch, KM; Hu, D; Brenner, S; Zöller, J; Heinz, GA; Nagel, D; Vogel, KU; Rehage, N; Warth, SC; Edelmann, SL; Gloury, R; Martin, N; Lohs, C; Lech, M; Stehklein, JE; Geerlof, A; Kremmer, E; Weber, A; Anders, HJ; Schmitz, I; Schmidt-Supprian, M; Fu, M; Holtmann, H; Krappmann, D; Ruland, J; Kallies, A; Heikenwalder, M; Heissmeyer, V
      Nature immunology  15  1079-89  2014

      Show Abstract
      25282160 25282160
      Roquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation.
      Vogel, KU; Edelmann, SL; Jeltsch, KM; Bertossi, A; Heger, K; Heinz, GA; Zöller, J; Warth, SC; Hoefig, KP; Lohs, C; Neff, F; Kremmer, E; Schick, J; Repsilber, D; Geerlof, A; Blum, H; Wurst, W; Heikenwälder, M; Schmidt-Supprian, M; Heissmeyer, V
      Immunity  38  655-68  2013

      Show Abstract
      23583643 23583643